Risks of valproate in porphyria

[Descriptive analysis of the electroencephalogram in Angelman syndrome].

Revista de neurologia·2021

[Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].

Revista de neurologia·2020

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

Neurologia·2020

12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II).

Revista de neurologia·2020

[12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)].

Revista de neurologia·2020

[Recommendations for the use of cladribine tablets in recurring multiple sclerosis].

Revista de neurologia·2020

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

How are testicular functions affected after morphine dependence and withdrawal in rats?

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases.

Frontiers in pharmacology·2026

Cardiac Safety Profile of Ziprasidone: A Real-World Pharmacovigilance Study Using FAERS and Network Toxicology.

Current neuropharmacology·2026

Addiction Specialists' Knowledge About and Assessment Practices for Kratom, Phenibut, and Tianeptine.

Substance use & addiction journal·2026

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series.

The American journal on addictions·2026

In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.

BMC pharmacology & toxicology·2026

Related Experiment Videos

Risks of valproate in porphyria

Related Concept Videos

[Descriptive analysis of the electroencephalogram in Angelman syndrome].

[Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].

Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement.

12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (II).

[12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)].

[Recommendations for the use of cladribine tablets in recurring multiple sclerosis].

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

How are testicular functions affected after morphine dependence and withdrawal in rats?

Exocytosed ATP as a therapeutic target for inflammatory and metabolic diseases.

Cardiac Safety Profile of Ziprasidone: A Real-World Pharmacovigilance Study Using FAERS and Network Toxicology.

Addiction Specialists' Knowledge About and Assessment Practices for Kratom, Phenibut, and Tianeptine.

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series.

In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models.

Related Experiment Videos

Risks of valproate in porphyria

Related Concept Videos

Related Articles